Following the inadvertent administration of a higher than recommended dose of the Pfizer COVID-19 vaccine to two aged-care residents, the following article discusses how this incident could happen and how we can aim to minimise the risk of it happening again.

Looking at data collected from clinical trials it is reassuring that this mistake is unlikely to have serious side effects. Moving forward it is suggested that supporting the education of immunisation providers, as well as enhancing the way we capture errors, will promote confidence in a COVID-19 vaccine rollout.

要阅读全文,请点击以下链接:

The Conversation: When vaccinating 26 million Australians, expect a mistake or two. But we can minimise the risk of repeating Queensland’s overdose incident